Innovative Surgical Technology SamanTree Medical has developed the Histolog Scanner, a CE-marked and FDA 510(k)-cleared imaging solution that enhances surgical precision through real-time tissue microstructure analysis, presenting significant opportunities to hospitals and surgical centers seeking advanced intraoperative imaging tools.

Strategic European Expansion With recent expansion of its European offices and substantial €20 million financing from the European Investment Bank, SamanTree Medical is scaling its commercial operations across Europe, creating potential for partnerships with regional distributors and healthcare providers.

US Market Entry Having achieved FDA clearance in 2024 and planning US market entry later that year, the company presents an opportunity to connect with U.S. hospitals and surgical specialists interested in innovative diagnostic imaging solutions.

Growing Funding Support Recent Series B funding of USD 14 million and over USD 23 million from the European Investment Bank demonstrate strong investor confidence, indicating promising financial stability and growth, which can be leveraged in sales pitches to prospects seeking proven technological innovation.

Targeted Healthcare Sector Operating in the medical equipment manufacturing industry with a focus on surgical imaging, SamanTree Medical is well-positioned to engage with hospitals, surgical centers, and diagnostic labs looking to upgrade to high-precision, cost-effective tissue imaging technology.